A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

Conditions: Major Depressive Episode (MDE); Major Depressive Disorder (MDD); Depression

Interventions: Drug: TNX-102 SL; Drug: Placebo sublingual tablet

Sponsors: Tonix Pharmaceuticals, Inc.

Recruiting